These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 30815897)

  • 1. The use of equine chondrogenic-induced mesenchymal stem cells as a treatment for osteoarthritis: A randomised, double-blinded, placebo-controlled proof-of-concept study.
    Broeckx SY; Martens AM; Bertone AL; Van Brantegem L; Duchateau L; Van Hecke L; Dumoulin M; Oosterlinck M; Chiers K; Hussein H; Pille F; Spaas JH
    Equine Vet J; 2019 Nov; 51(6):787-794. PubMed ID: 30815897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equine allogeneic chondrogenic induced mesenchymal stem cells: A GCP target animal safety and biodistribution study.
    Broeckx SY; Spaas JH; Chiers K; Duchateau L; Van Hecke L; Van Brantegem L; Dumoulin M; Martens AM; Pille F
    Res Vet Sci; 2018 Apr; 117():246-254. PubMed ID: 29329028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic vs. autologous intra-articular mesenchymal stem cell injection within normal horses: Clinical and cytological comparisons suggest safety.
    Colbath AC; Dow SW; Hopkins LS; Phillips JN; McIlwraith CW; Goodrich LR
    Equine Vet J; 2020 Jan; 52(1):144-151. PubMed ID: 31120574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrin α10β1-Selected Mesenchymal Stem Cells Mitigate the Progression of Osteoarthritis in an Equine Talar Impact Model.
    Delco ML; Goodale M; Talts JF; Pownder SL; Koff MF; Miller AD; Nixon B; Bonassar LJ; Lundgren-Åkerlund E; Fortier LA
    Am J Sports Med; 2020 Mar; 48(3):612-623. PubMed ID: 32004077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equine Allogeneic Chondrogenic Induced Mesenchymal Stem Cells Are an Effective Treatment for Degenerative Joint Disease in Horses.
    Broeckx SY; Seys B; Suls M; Vandenberghe A; Mariën T; Adriaensen E; Declercq J; Van Hecke L; Braun G; Hellmann K; Spaas JH
    Stem Cells Dev; 2019 Mar; 28(6):410-422. PubMed ID: 30623737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of efficacy and safety of single versus repeated intra-articular injection of allogeneic neonatal mesenchymal stem cells for treatment of osteoarthritis of the metacarpophalangeal/metatarsophalangeal joint in horses: A clinical pilot study.
    Magri C; Schramme M; Febre M; Cauvin E; Labadie F; Saulnier N; François I; Lechartier A; Aebischer D; Moncelet AS; Maddens S
    PLoS One; 2019; 14(8):e0221317. PubMed ID: 31465445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single and repeated intra-articular injections in the tarsocrural joint with allogeneic and autologous equine bone marrow-derived mesenchymal stem cells are safe, but did not reduce acute inflammation in an experimental interleukin-1β model of synovitis.
    Colbath AC; Dow SW; Hopkins LS; Phillips JN; McIlwraith CW; Goodrich LR
    Equine Vet J; 2020 Jul; 52(4):601-612. PubMed ID: 31821594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of effectiveness and safety of repeat administration of proinflammatory primed allogeneic mesenchymal stem cells in an equine model of chemically induced osteoarthritis.
    Barrachina L; Remacha AR; Romero A; Vitoria A; Albareda J; Prades M; Roca M; Zaragoza P; Vázquez FJ; Rodellar C
    BMC Vet Res; 2018 Aug; 14(1):241. PubMed ID: 30119668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of exercise and polysulfated glycosaminoglycan on the development of osteoarthritis in equine carpal joints with osteochondral defects.
    Todhunter RJ; Freeman KP; Yeager AE; Lust G
    Vet Surg; 1993; 22(5):330-42. PubMed ID: 8236786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of an osteochondral fragment-groove procedure for induction of metacarpophalangeal joint osteoarthritis in horses.
    Broeckx SY; Pille F; Buntinx S; Van Brantegem L; Duchateau L; Oosterlinck M; Chiers K; Bertone AL; Spaas JH; Martens AM
    Am J Vet Res; 2019 Mar; 80(3):246-258. PubMed ID: 30801207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equine allogeneic umbilical cord blood derived mesenchymal stromal cells reduce synovial fluid nucleated cell count and induce mild self-limiting inflammation when evaluated in an lipopolysaccharide induced synovitis model.
    Williams LB; Koenig JB; Black B; Gibson TW; Sharif S; Koch TG
    Equine Vet J; 2016 Sep; 48(5):619-25. PubMed ID: 26114736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory effects of autologous, genetically modified autologous, allogeneic, and xenogeneic mesenchymal stem cells after intra-articular injection in horses.
    Pigott JH; Ishihara A; Wellman ML; Russell DS; Bertone AL
    Vet Comp Orthop Traumatol; 2013; 26(6):453-60. PubMed ID: 24080668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of equine mesenchymal stem cells from healthy and injured synovial tissues: an in vitro assessment.
    Fülber J; Maria DA; da Silva LC; Massoco CO; Agreste F; Baccarin RY
    Stem Cell Res Ther; 2016 Mar; 7():35. PubMed ID: 26944403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of extracorporeal shock wave therapy and polysulfated glycosaminoglycan treatment on subchondral bone, serum biomarkers, and synovial fluid biomarkers in horses with induced osteoarthritis.
    Kawcak CE; Frisbie DD; McIlwraith CW
    Am J Vet Res; 2011 Jun; 72(6):772-9. PubMed ID: 21627523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concepts and challenges in the use of mesenchymal stem cells as a treatment for cartilage damage in the horse.
    Zayed M; Adair S; Ursini T; Schumacher J; Misk N; Dhar M
    Res Vet Sci; 2018 Jun; 118():317-323. PubMed ID: 29601969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regenerative therapies for equine degenerative joint disease: a preliminary study.
    Broeckx S; Zimmerman M; Crocetti S; Suls M; Mariën T; Ferguson SJ; Chiers K; Duchateau L; Franco-Obregón A; Wuertz K; Spaas JH
    PLoS One; 2014; 9(1):e85917. PubMed ID: 24465787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the Chondrogenic Potential of Mesenchymal Stem Cells Derived from Bone Marrow and Umbilical Cord Blood Intended for Cartilage Tissue Engineering.
    Contentin R; Demoor M; Concari M; Desancé M; Audigié F; Branly T; Galéra P
    Stem Cell Rev Rep; 2020 Feb; 16(1):126-143. PubMed ID: 31745710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-1ra gene therapy in equine osteoarthritis improves physiological, anatomical, and biological outcomes of joint degeneration.
    Goodrich LR; McIlwraith CW; Grieger J; Kraus VB; Stabler T; Werpy N; Phillips J; Samulski RJ; Frisbie D
    J Am Vet Med Assoc; 2024 Jun; 262(S1):S109-S120. PubMed ID: 38631386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Allogeneic Bone-Marrow-Derived and Umbilical Cord Blood-Derived Mesenchymal Stem Cells to Prevent the Development of Osteoarthritis in An Equine Model.
    Bertoni L; Jacquet-Guibon S; Branly T; Desancé M; Legendre F; Melin M; Rivory P; Hartmann DJ; Schmutz A; Denoix JM; Demoor M; Audigié F; Galéra P
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33801461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated intra-articular administration of equine allogeneic peripheral blood-derived mesenchymal stem cells does not induce a cellular and humoral immune response in horses.
    Van Hecke L; Magri C; Duchateau L; Beerts C; Geburek F; Suls M; Da Dalt L; Patruno M; Saunders J; Broeckx SY; Depuydt E; Spaas JH
    Vet Immunol Immunopathol; 2021 Sep; 239():110306. PubMed ID: 34365135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.